David R Blonski

Title: David R. Blonski: Innovator in Aqueous FK506 Standards

Introduction

David R. Blonski is an accomplished inventor based in Kenosha, Wisconsin. He holds a patent that contributes significantly to the field of biochemistry, particularly in the stabilization of FK506 in aqueous compositions. His work serves as a vital resource for research and development in the pharmaceutical industry.

Latest Patents

David's notable patent is titled "Stable Aqueous FK506 Standards". This invention presents a stabilized, aqueous composition that includes FK506, which typically degrades rapidly in most aqueous environments. His innovative approach reveals that the degradation rate can be significantly decreased when unfixed blood cells or fragments of blood cells from human or animal sources are present. This groundbreaking method opens up multiple avenues for utilizing blood components—whether directly or through lysed blood cells—diluted with an alkali halide solution.

Career Highlights

David R. Blonski works at Abbott Laboratories Corporation, a prominent firm in the healthcare sector. His responsibilities involve researching and developing new formulations that enhance stability and efficacy. With a single yet impactful patent under his name, he continues to push the boundaries of innovation in his field.

Collaborations

Throughout his career, David has collaborated with talented individuals like Frank C. Grenier and Julie A. Luczkiw. These partnerships have fostered a dynamic environment for innovation and have contributed to the advancement of their respective projects at Abbott Laboratories Corporation.

Conclusion

David R. Blonski exemplifies the spirit of innovation through his contributions to aqueous FK506 standards. His patent serves as a testament to the power of collaboration and creativity in problem-solving within the pharmaceutical industry. As he continues his work, the potential for further contributions to the field remains promising.